Authors:
ABOULJOUD MS
BROWN KA
MAY E
BALIAD P
ESCOBAR FS
MOZES MF
Citation: Ms. Abouljoud et al., COST-EFFECTIVE MANAGEMENT OF ACUTE REJECTION IN LIVER-TRANSPLANT RECIPIENTS - A MANAGED CARE PERSPECTIVE, Transplantation proceedings, 29(1-2), 1997, pp. 1557-1559
Authors:
MAY EJ
BROWN KA
HOCKING N
MOZES MF
ABOULJOUD MS
Citation: Ej. May et al., SUCCESSFUL LONG-TERM CHOLESTEROL REDUCTION USING HMG CO A REDUCTASE INHIBITORS IN LIVER-TRANSPLANT RECIPIENTS, Hepatology, 24(4), 1996, pp. 207-207
Authors:
ABOULJOUD MS
ESCOBAR F
MOZES MF
BROWN K
MAY E
Citation: Ms. Abouljoud et al., SAFETY AND EFFICACY OF TOTAL PERCUTANEOUS PORTOSYSTEMIC VENOVENOUS BYPASS IN LIVER-TRANSPLANTATION, Hepatology, 24(4), 1996, pp. 1396-1396
Authors:
ABOULJOUD MS
NAKHLEH R
PETERSON C
HOCKING N
BROWN K
MAY E
ESCOBAR F
MOZES MF
Citation: Ms. Abouljoud et al., PREDICTION OF STEROID-RESPONSE - IN THE TREATMENT OF ACUTE LIVER ALLOGRAFT-REJECTION - COMPARISON OF GRADING SYSTEMS, Hepatology, 24(4), 1996, pp. 1397-1397
Authors:
BROWN KA
ABOULJOUD MS
ESCOBAR FS
MOZES MF
Citation: Ka. Brown et al., INTERNAL BILIARY STENTING VS T-TUBE DRAINAGE FOR ORTHOTOPIC LIVER-TRANSPLANTATION - EVALUATION OF SAFETY AND EFFICACY, Hepatology, 24(4), 1996, pp. 1447-1447
Authors:
BROWN KA
PETERSON C
NAKHLEH R
ABOULJOUD MS
MAY EJ
HOCKING N
BENMENACHEM T
ESCOBAR F
MOZES M
Citation: Ka. Brown et al., LIVER-BIOPSY AND LIVER BIOCHEMISTRIES DO NOT PREDICT OUTCOME FOLLOWING OKT3 OR ATGAM THERAPY, Hepatology, 24(4), 1996, pp. 1448-1448
Citation: Ms. Abouljoud et al., HYPERLIPIDEMIA AFTER LIVER-TRANSPLANTATION - LONG-TERM RESULTS OF THEFK506 CYCLOSPORINE - A US MULTICENTER TRIAL, Transplantation proceedings, 27(1), 1995, pp. 1121-1123
Authors:
MULLIGAN DC
GOLDSTEIN RM
CRIPPIN JS
ABOULJOUD MS
LEVY MF
HUSBERG BS
GONWA TA
FOSTER BRN
TILLERY GW
KLINTMALM GB
Citation: Dc. Mulligan et al., USE OF ANTI-HEPATITIS-C VIRUS-SEROPOSITIVE ORGANS IN LIVER-TRANSPLANTATION, Transplantation proceedings, 27(1), 1995, pp. 1204-1205
Authors:
ABOULJOUD MS
DEIERHOI MH
HUDSON SL
DIETHELM AG
Citation: Ms. Abouljoud et al., RISK-FACTORS AFFECTING 2ND RENAL-TRANSPLANT OUTCOME, WITH SPECIAL REFERENCE TO PRIMARY ALLOGRAFT NEPHRECTOMY, Transplantation, 60(2), 1995, pp. 138-144
Authors:
ABOULJOUD MS
LEVY MF
REES CR
DIAMOND NG
LEE SP
MULLIGAN DC
GOLDSTEIN RM
HUSBERG B
GONWA TA
KLINTMALM GB
Citation: Ms. Abouljoud et al., A COMPARISON OF TREATMENT WITH TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT OR DISTAL SPLENORENAL SHUNT IN THE MANAGEMENT OF VARICEAL BLEEDING PRIOR TO LIVER-TRANSPLANTATION, Transplantation, 59(2), 1995, pp. 226-229
Authors:
MULLIGAN DC
GOLDSTEIN RM
LEVY MF
ABOULJOUD MS
HUSBERG BS
GONWA TA
STONE MJ
KLINTMALM GB
Citation: Dc. Mulligan et al., LIVER-TRANSPLANTATION FOR HEPATOCELLULAR-CARCINOMA - A COMPARISON OF OUTCOMES BETWEEN PATIENTS TREATED WITH NEOADJUVANT CHEMOTHERAPY PRE-OLTX AND THOSE WITH INCIDENTAL HEPATOMAS, Hepatology, 20(4), 1994, pp. 10000119-10000119
Authors:
MULLIGAN DC
GOLDSTEIN RM
CRIPPIN JS
ABOULJOUD MS
LEVY MF
HUSBERG BS
GONWA TA
FOSTER B
KLINTMALM GB
Citation: Dc. Mulligan et al., CAN ANTI-HEPATITIS-C VIRUS-SEROPOSITIVE ORGANS SAFELY BE USED FOR LIVER-TRANSPLANTATION, Hepatology, 20(4), 1994, pp. 10000119-10000119